These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2004-004801-11||A Phase II, Multicenter, Double-Blind, Efficacy, Safety, and Tolerability Study of ZP120 Administered as Short Term I.V. Infusion as Add-On Therapy in Patients with Subacute Decompensated Chronic Hear...||not-yet-due|
|Not reported||2013-002312-27||A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess Clinical Efficacy and Safety of Danegaptide in Patients with ST-Elevation Myocardial Infarction undergoing Primary Percut...||2015-12-04||due-trials|
|Reported results||2015-002826-38||A phase 2 trial testing ZP1848 in patients with SBS||2017-05-04||due-trials|
|Not reported||2015-005287-41||A randomized, double-blind trial of single doses of ZP4207 administered s.c. to hypoglycemic Type 1 diabetic patients to describe the pharmacokinetics and pharmacodynamics of ZP4207 as compared to mar...||2016-06-03||due-trials|
|Not reported||2016-002617-21||A randomised, sequential, cross-over trial assessing pharmacokinetic and pharmacodynamic responses after micro-doses of ZP4207 administered subcutaneously to patients with type 1 diabetes mellitus und...||2017-04-05||due-trials|
|Completed, reported early||2017-000062-30||A phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients with Type 1 Diabetes Mellitus (T1D...||2018-02-13||not-yet-due|
|Completed, report not yet due||2017-002449-31||A phase 3, randomized, double-blind, parallel trial to confirm the clinical efficacy and safety of dasiglucagon in the rescue treatment of hypoglycemia in subjects with type 1 diabetes mellitus (T1DM)...||2018-05-25||not-yet-due|
|Ongoing||2017-004394-14||A Phase 3, international, multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of glepaglutide in patients with short bowel syndrome (SBS)||not-yet-due|
|No trial status on register||2017-004545-24||A Randomized, Double-Blind, Parallel-Group Trial Evaluating the Efficacy and Safety of Dasiglucagon for the Treatment of Children with Congenital Hyperinsulinism||bad-data|
|Ongoing||2017-004547-21||A Two-Period, Open-label Trial Evaluating the Efficacy and Safety of||not-yet-due|
|Ongoing||2018-000892-33||A phase 3, randomized, double-blind, placebo- and active-controlled, parallel-arm trial to assess the efficacy, safety, and pharmacokinetics of dasiglucagon relative to placebo and GlucaGen® when admi...||not-yet-due|